5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001806:Blood Urea Nitrogen; D002175:Candida / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D003453:Cryptococcosis / Q000188:drug therapy*; D003454:Cryptococcus / Q000187:drug effects; D003596:Cytosine / Q000008:administration & dosage / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004696:Endocarditis / Q000188:drug therapy; D005461:Fluorine / Q000008:administration & dosage / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D008875:Middle Aged; D011183:Postoperative Complications
D000935:Antifungal Agents; D005461:Fluorine; D000666:Amphotericin B; D003596:Cytosine